Oxford Biomedica Plc (OXBDF)
Oxford Biomedica Market Cap : 899.25M for April 8, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 5.301M |
| Biodexa Pharmaceuticals Plc | 2.276M |
| NuCana Plc | 7.908M |
| Autolus Therapeutics Plc | 396.55M |
Market Cap Related Metrics
| PS Ratio | 3.784 |
| Price | 7.438 |
| Earnings Yield | -4.90% |